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        Introduction 
  Chlamydia trachomatis  , an obligate intracellular bacterium, is 
the leading cause of bacterially sexually transmitted disease and 
a main cause of preventable blindness.   C. trachomatis   has  a 
  biphasic developmental cycle. The infectious elementary body 
(EB) infects primarily epithelial cells where it develops within 
a membrane-bound vacuole (called an inclusion) into a replicat-
ing noninfectious reticulate body (RB). Within two days, the 
RB redifferentiates into an EB and is released from the infected 
cell. Chlamydiae thus develop in a compartment that is separate 
from the rest of the human or animal host cell. However, the 
bacteria impact on a number of signaling pathways in the host 
cell, and cause substantial changes to cellular transcription as 
well as cell damage (  McClarty, 1994  ;   Wyrick, 2000  ;   Fields and 
Hackstadt, 2002  ). How   Chlamydia   achieves this is not known in 
great detail. Several chlamydial species have been found to pos-
sess the components of a functional type III secretion system, 
which likely enables the bacteria to inject effector proteins into 
the host cytosol, and a number of such candidate proteins have 
been identifi  ed (for review see   Peters et al., 2007  ). 
  Infection with   Chlamydia   causes massive stress to the host 
cell, and cytolytic activity associated with   Chlamydia   infection 
has been described for more than 30 years (  Friis, 1972  ;   Todd 
and Storz, 1975  ;   Chang and Moulder, 1978  ;   Wyrick et al., 1978  ). 
By electron microscopy, massive changes to organelles were 
noticed at later stages of infection, such as dilation and vacuola-
tion of ER, distortion of mitochondria, and nuclear condensation 
(  Todd and Storz, 1975  ;   Todd et al., 1976  ). Although some of 
these changes resemble features of apoptosis (  Ojcius et al., 
1998  ;   Perfettini et al., 2002  ;   Ying et al., 2006  ), further charac-
terization of signaling pathways indicates that the apoptotic path-
way is not activated by   Chlamydia   and the cytopathic changes 
observed are nonapoptotic (  Ying et al., 2006  ). Cytopathicity and 
cell death may be a defense mechanism of the cell to block 
  bacterial replication or may aid bacterial spreading and cause 
infection-associated infl  ammation. 
  It has been entirely unclear how   Chlamydia   induces  cell 
death. The gene of a potential cytotoxin has been identifi  ed in the 
  C. trachomatis   genome (  Belland et al., 2001  ), but was later found 
to be nonfunctional in many serovars (  Carlson et al., 2004  ). 
  C
hlamydiae replicate in a vacuole within epithelial 
cells and commonly induce cell damage and a 
deleterious inﬂ   ammatory response of unknown 
molecular pathogenesis. The chlamydial protease-like 
  activity factor (CPAF) translocates from the vacuole to the 
cytosol, where it cleaves several cellular proteins. CPAF is 
synthesized as an inactive precursor that is processed and 
activated during infection. Here, we show that CPAF can 
be activated in uninfected cells by experimentally induced 
oligomerization, reminiscent of the activation mode of 
  initiator caspases. CPAF activity induces proteolysis of 
  cellular substrates including two novel targets, cyclin B1 
and PARP, and indirectly results in the processing of pro-
apoptotic BH3-only proteins. CPAF activation induces 
striking morphological changes in the cell and, later, cell 
death. Biochemical and ultrastructural analysis of the cell 
death pathway identify the mechanism of cell death as 
nonapoptotic. Active CPAF in uninfected human cells thus 
mimics many features of chlamydial infection, implicating 
CPAF as a major factor of chlamydial pathogenicity, 
    Chlamydia  -associated cell damage, and inﬂ  ammation.
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sors, both are proteolytically processed into two subunits during 
their physiological activation, and in both cases the active 
enzyme is made up of a complex of both subunits. We there-
fore aimed at achieving experimental oligomerization of CPAF 
to model the physiological clustering of caspase-9 after its re-
cruitment into the apoptosome during apoptosis (  Bao and Shi, 
2007  ). The open reading frame of   C. trachomatis   CPAF was 
fused to an N-terminal partner consisting of the FLAG antibody 
epitope and a triple repeat of a fragment of bacterial gyrase (gyr) B. 
GyrB binds the cell-permeable synthetic ligand coumermycin 
(CM). Because CM has two gyrB binding sites, it can bind two 
gyrB proteins simultaneously, inducing dimerization of the fu-
sion partner of gyrB (  Fig. 1 A  ). A triple repeat rather than an indi-
vidual gyrB molecule was chosen to enhance complex formation 
upon CM addition. We and others have used this system in the 
past for conditional complex formation of intracellular signaling 
proteins (  Farrar et al., 1996  ;   Hacker et al., 2006  ). Because tran-
sient transfections indicated that the protein was toxic to human 
cells (unpublished data), the fusion construct was placed under 
the control of a tetracycline (TET)-inducible promoter, where ex-
pression was silenced in cells carrying the tet-repressor but in-
duced upon addition of tetracycline (  “  tet-on  ”  ). 
 When the gyrB-CPAF construct was transfected into 293T 
cells stably carrying the tet-repressor (T-REx-293), the addition 
of tetracycline or its analogue anhydrotetracycline (AHT) in-
duced the appearance of a protein of the expected size of the 
full-length protein as well as a smaller product, which ran at the 
expected size of a protein containing the N-terminal tag fused 
to the N-terminal CPAF-fragment, indicating processing of the 
protein (  Fig. 1 B  ). 
  T-REx-293 cells were then transfected and clones were se-
lected that stably carried the TET-inducible gyrB-CPAF con-
struct. Five clones were identifi  ed, in which addition of TET/AHT 
induced expression of a protein of the same size as the smaller 
product during transient transfection, again very likely cor-
responding to the fragment of gyrB and the N-terminal fragment 
of CPAF ( Fig. 1 B  and unpublished data). No band corresponding 
to the intact protein was detected in these clones, suggesting more 
effi  cient processing. All of the clones showed the same pheno-
type upon induction of gyrB-CPAF (see following paragraph). 
Expression of gyrB-CPAF thus leads to spontaneous processing 
of the protein. 
 To test for CM-mediated oligomerization, cell extracts from 
the stable clone K6 expressing gyrB-CPAF were analyzed by 
size exclusion chromatography. GyrB-N-CPAF was detectable 
with a peak around the expected molecular weight of the pro-
tein (120 kD). Addition of CM caused a shift in the protein to 
higher molecular weight fractions (  Fig. 1 C  ). Because of the low 
expression of wild-type gyrB-CPAF, we performed additional 
experiments with a cleavage-defi  cient mutant of gyrB-CPAF 
(CPAFmut1 [see following paragraph], which is expressed at 
considerably higher levels), expressed by transient transfection 
and induction in T-REx-293 cells. As shown in   Fig. 1 C  , most of 
the protein eluted at about the predicted size of the unprocessed 
monomer (150 kD), although easily detectable amounts appeared 
in fractions containing higher molecular weight proteins. Addi-
tion of CM caused a shift of the protein peak, which then eluted 
  One chlamydial protein has been directly purifi  ed from the 
cytosol of infected cells. Named chlamydial protease-like activity 
factor (CPAF), this protein was isolated as a factor that can de-
grade two host transcription factors, RFX5 and USF-1 (  Zhong 
et al., 2001  ). Because these transcription factors are involved in 
the expression of major histocompatibility complex (MHC) mol-
ecules, it has been speculated that CPAF may contribute to im-
mune evasion of   Chlamydia   (  Zhong et al., 2001  ). Similarly, it has 
been suggested that CPAF plays a role in the loss of expression of 
the MHC-like protein CD1d during infection, which may also 
enhance escape from host immune surveillance (  Kawana et al., 
2007  ). The cytoskeletal protein cytokeratin (CK) 8, a component 
of intermediate fi  laments, has also been identifi  ed as a substrate 
of CPAF proteolysis (  Dong et al., 2004c  ), and recently it has been 
proposed that the pro-apoptotic BH3-only proteins, which are 
degraded during chlamydial infection (  Fischer et al., 2004  ;   Ying 
et al., 2005  ), are CPAF substrates (  Pirbhai et al., 2006  ). Because 
  Chlamydia   cannot be genetically modifi  ed, direct proof of the 
role of CPAF has been diffi  cult. 
  CPAF is synthesized in the chlamydial inclusion as one 
polypeptide, but is rapidly processed into two subunits that as-
semble into heterodimers and are proteolytically active in the 
host cytosol (  Dong et al., 2004a,b  ). Expression of the CPAF 
precursor in human cells did not induce CPAF processing and 
yielded no proteolytic activity (  Dong et al., 2004a  ). 
  Although potential functions had thus been assigned to 
CPAF, we reasoned that an active protease, free in the cytosol 
of a human cell, may be expected to damage the cell, and that 
CPAF therefore should be a candidate factor for cytopathic ac-
tivity. However, until now it has not been possible to express 
active CPAF in human cells in the absence of infection, and 
meaningful analysis of CPAF effects in infected cells is very 
diffi  cult due to the presence of numerous bacterial components 
in the cell. 
  We here show that CPAF can be activated by   “  induced 
proximity  ”   in the absence of infection. The induced proximity 
model was proposed to explain the activation of initiator cas-
pases during induction of apoptosis (  Salvesen and Dixit, 1999  ; 
  Pop et al., 2006  ;   Bao and Shi, 2007  ). According to this model, 
the dimerization and activation of initiator caspases requires 
their adaptor-mediated clustering, followed by caspase process-
ing. Similarly, we describe that forced clustering of CPAF leads 
to its processing and activation in human cells. Activation of 
CPAF caused massive morphological changes and nonapoptotic 
death of human host-cells, strongly resembling the changes and 
the form of cell death induced by chlamydial infection. CPAF 
should therefore be regarded as a major factor of chlamydial 
pathogenicity. CPAF activity may help   Chlamydia   at  earlier 
stages to establish the growing inclusion in the cell and at later 
stages may facilitate release of newly replicated bacteria. 
  Results 
  Activation of CPAF by induced proximity 
  To study the role of CPAF in cytopathicity, a model had to be de-
veloped to express active CPAF. We had noticed certain parallels 
of caspase-9 and CPAF. Both are synthesized as inactive precur-119 CYTOPATHICITY OF CPAF   • Paschen et al. 
  CPAF activity requires its processing site 
and an intact protease motif 
  CPAF activity in lysates from infected cells was inhibited by an 
inhibitor of the cellular proteasome, lactacystin, but not another 
one, MG-132 (  Zhong et al., 2001  ). We used CPAF K6 cell ly-
sate as a source of CPAF and lysate from cells transfected with 
a construct encoding myc-tagged CK8 as a substrate, to test for 
the effects of standard protease inhibitors on CPAF. Lactacystin 
but not MG-132, nor any other tested inhibitor, prevented deg-
radation of CK8 (  Fig. 2 A   and unpublished data). (The follow-
ing inhibitors were tested: E64, pepstatin A, PMSF, TPCK, and 
a standard mix of protease inhibitors [Roche].) These results 
confi  rm the inhibitory activity of lactacystin previously reported 
in lysates from infected cells and identify an unusual inhibitor 
profi  le for CPAF. 
  It has been shown that a small amount of CPAF is cleaved 
when expressed in   Escherichia coli  , and the processing site has 
been mapped; a cleavage site mutant was not processed and was 
inactive when expressed in   E. coli   (  Dong et al., 2004a  ). It has 
further been noted that CPAF contains a domain characteristic 
of bacterial Tail-specifi  c proteases (Tsp) (  Shaw et al., 2002  ), a 
class of serine proteases originally described in   E. coli   ( Silber 
et al., 1992  ). We therefore generated gyrB-CPAF constructs with 
around 500 kD and might correspond to a trimer or tetramer of 
the protein. A substantial fraction of the protein appeared to be 
engaged in formation of even higher molecular weight com-
plexes. Most of these CM-induced complexes could be disrupted 
by addition of an excess of the monomeric ligand of gyrase B, 
novobiocin (NB) (  Fig. 1 C  ). These results show the expected 
oligomerization of gyrB-CPAF by CM, as well as substantial 
spontaneous complex formation. The spontaneous oligomeriza-
tion was probably due to the gyrase B domains because novobiocin 
could reduce the extent of complex formation (compare lanes AHT 
and AHT/CM/NB in gyrB-CPAFmut1;   Fig. 1 C  ). 
  We next measured the proteolytic activity of gyrB-CPAF, 
using cleavage of CK8, one of the reported cellular CPAF sub-
strates, as a read-out. As shown in   Fig. 1 D  , titration of AHT on 
the CPAF K6 clone caused increasing cleavage of CK8 even 
in the absence of CM-induced oligomerization, suggesting that 
spontaneous aggregation was suffi  cient for activation of gyrB-
CPAF. Addition of CM to cells induced with a lower concentra-
tion of AHT caused a higher level of CK8 degradation, which 
could be partly blocked by increasing concentrations of novo-
biocin (  Fig. 1 D  ). GyrB-CPAF thus shows some spontaneous ag-
gregation and activity, which can be enhanced by CM; the effect 
of CM can be prevented by NB. 
  Figure 1.       CPAF is activated by induced proximity.   (A) Schematic representation of the gyrB-CPAF construct. CPAF was placed under the control of a 
tetracycline-inducible promoter. FLAG, FLAG tag; 3xgyrB, three consecutive copies of an N-terminal fragment of gyrase B from   Escherichia coli  ; CPAF, CPAF 
from   Chlamydia trachomatis   (amino acid residues 18  –  601). (B) CPAF expression in T-Rex-293 cells. Expression of CPAF was induced by tetracycline (TET) 
either in CPAF K6 cells stably expressing gyrB-CPAF or T-REx-293 cells transfected with the gyrB-CPAF construct. CPAF-N indicates an N-terminal fragment 
of gyrB-CPAF after proteolytic activation. Triton X-100 cell extracts were analyzed by Western blotting with an antibody speciﬁ  c for the FLAG tag. Asterisk, 
unspeciﬁ  c signal. Molecular size markers (in kD) are indicated. (C) Size exclusion chromatography of CPAF. Cell extracts of either CPAF K6 cells (top) or 
T-REx-293 cells transfected with the CPAFmut1 (carrying the S491A active-site mutation; bottom) were separated on a Superose 200 gel ﬁ  ltration column. 
Anhydrotetracycline (AHT), coumermycin (CM), or novobiocin (NB) were used as indicated. The elution fractions and eluted molecular size markers are 
indicated. (D) Activation of CPAF by induced proximity. CPAF expression was induced in CPAF K6 cells with increasing amounts (top) of AHT or using 
0.5 ng/ml (bottom). Before addition of CM, cells were preincubated with indicated amounts of NB. Samples were analyzed by Western blotting using 
anti-CK8 antibodies. The arrowhead indicates a cleavage product of CK8. Detection of actin served as a loading control.     JCB • VOLUME 182 • NUMBER 1 • 2008  120
CPAF. A number of control proteins (Bak, Bcl-2, actin) were not 
degraded (  Fig. 3  ; see following paragraph regarding cleavage of 
BH3-only proteins). The expression of active CPAF thus recapit-
ulates the known proteolytic activities observed during infection 
with whole chlamydiae. Based on the levels of substrate cleav-
age, the amount of active gyrB-CPAF produced corresponds to 
the levels of CPAF expressed relatively early in the developmen-
tal cycle, at least in T-REx-293 cells. The amounts generated dur-
ing later stages of infection are probably substantially higher and 
cause more complete degradation of cellular substrates (  Fig. 3  ). 
  Degradation of anti-apoptotic BH3-only 
proteins is likely an indirect consequence 
of CPAF expression 
  BH3-only proteins are essential mediators of mitochondrial 
apoptosis (  Hacker and Weber, 2007  ). These proteins are de-
graded during chlamydial infection (  Fischer et al., 2004  ), which 
can account for the protection against apoptosis of infected 
cells. Re-expression of active BH3-only proteins overcomes the 
  Chlamydia  -imposed block of apoptosis (  Fischer et al., 2004  ), 
indicating that this loss is functionally relevant. It has recently 
been reported that CPAF can degrade BH3-only proteins in cell 
lysates (  Pirbhai et al., 2006  ). In our initial analyses, we failed 
to see degradation of the BH3-only proteins Bim and Puma 
(unpublished data), which were easily detectable in CPAF K6 cells, 
point mutations either in the active site of the Tsp domain 
(S491A, CPAFmut1) or in the processing site (L273G, S275V, 
CPAFmut2). When expressed transiently in T-REx-293 cells, 
neither mutant was processed (  Fig. 2 B  , top) and neither was 
able to cleave endogenous CK8 (  Fig. 2 B  , bottom) or myc-
tagged CK8 in a cell-free system using lysate from transfected 
cells (  Fig. 2 C  ). This suggests that CPAF is cleaved autocatalyti-
cally and the Tsp domain containing the active-site serine resi-
due is indeed required for its proteolytic activity. 
  A number of host cell proteins have been reported to be 
cleaved by CPAF during chlamydial infection, including CK8, 
the transcription factors RFX5 and USF-1, and the BH3-only 
proteins Bim, Puma, and Bik (  Zhong et al., 2001  ;   Dong et al., 
2004c  ). Another protein, the component of intermediate fi  la-
ments, vimentin, was also recently shown to be cleaved by CPAF 
(Valdivia, R., personal communication). We therefore tested the 
cleavage of these proteins upon CPAF activation in K6 cells. 
Cleavage of CK8, RFX5, and vimentin occurred upon CPAF ac-
tivation in K6 cells and yielded fragments of the same sizes as 
during infection with   C. trachomatis   (  Fig. 3  ), whereas USF1 was 
not detectable by Western blotting in these cells. The cell cycle 
protein cyclin B1 is also degraded during chlamydial infection 
(  Balsara et al., 2006  ). Degradation products of the same sizes as 
during infection were generated upon activation of CPAF, sug-
gesting that cleavage of cyclin B1 during infection is mediated by 
  Figure 2.       Analysis of proteolytic activity of CPAF.   (A) Inhibition of CPAF activity by proteasome inhibitors. Cell extracts of CPAF K6 cells (gyrB-CPAF) or 
T-REx-293 cells expressing myc-tagged cytokeratin 8 (CK8-myc) were combined in the presence of various amounts of the proteasome inhibitors lactacystin 
(LC; top) or MG-132 (bottom) as indicated, and analyzed by Western blotting using an antibody speciﬁ  c for the myc tag. The arrowhead indicates a 
cleavage product of CK8-myc (asterisk marks an unspeciﬁ  c signal). (B) Analysis of the proteolytic activity of CPAF mutants in vivo. T-REx-293 cells were 
transfected with either the gyrB-CPAF construct or one of two CPAF mutants. In CPAFmut1, the Tsp-active site was mutated by the replacement S491A. 
In mutant 2 (CPAFmut2), two amino acid residues (L273G, S275V) were exchanged to prevent autocatalytic cleavage of CPAF. CPAF expression was 
induced by AHT as indicated. Cell extracts were analyzed by Western blotting using either FLAG tag (top) or CK8 antibodies (bottom). The arrowhead in 
the top panel shows the cleavage product very likely corresponding to gyrB-CPAF-N; the arrowhead in the bottom panel indicates a cleavage product of 
CK8. An unspeciﬁ  c signal is marked by an asterisk. (C) Analysis of the proteolytic activity of CPAF mutants in vitro. T-REx-293 cells were transfected with the 
CPAF constructs as indicated, and cell lysates were incubated with extracts containing myc-tagged CK8, and analyzed as described in A (top). Expression 
of the CPAF constructs was conﬁ  rmed by Western blotting using a FLAG tag antibody (bottom).     121 CYTOPATHICITY OF CPAF   • Paschen et al. 
question of the cellular consequences of CPAF activity. On the 
one hand, CPAF induced the degradation of BH3-only proteins 
and is therefore an anti-apoptotic effector. On the other hand, free 
proteases in the cytosol have the potential to cause cell death. 
This has been shown not only for the specialized caspases, but also, 
for example, for lysosomal peptidases (  Lockshin and Zakeri, 
2004  ) and even the promiscuous protease proteinase-K (  Wilhelm 
and Hacker, 1999  ). Chlamydial infection causes massive mor-
phological changes to the host cell as well as nonapoptotic cell 
death (  Ojcius et al., 1998  ;   Belland et al., 2001  ;   Perfettini et al., 
2002  ;   Ying et al., 2006  ). We therefore asked whether CPAF might 
contribute to this cytopathicity. 
  The expression and activation of CPAF in K6 cells (  Fig. 5 A  ) 
caused striking morphological changes in the cells. The cells 
rounded up and began to detach from the culture dish. They 
formed clusters and at later stages, smaller vesicular fragments 
appeared (  Fig. 5 A  ). Similar albeit less pronounced changes 
were observed upon transient transfection and activation of gyrB-
CPAF in T-REx-293 or T-REx-HeLa cells (Fig. S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200804023/DC1). Indeed, 
the morphology resembled the changes observed during chla-
mydial infection of T-REx-293 cells (Fig. S2). Although not 
conclusive, this similarity suggests that CPAF is involved in at 
least some of the morphological changes induced during chla-
mydial infection. AHT on its own caused less dramatic changes 
in CPAF K6 cells than when CM was included, and an excess of 
novobiocin could reduce the phenotypical changes (  Fig. 5 B  ). 
Cleavage of cellular proteins by CPAF may therefore be one 
mechanism by which   Chlamydia   induces the morphological 
changes observed in the host cell. 
  The dramatic changes as observed by microscopy sug-
gested that K6 cells expressing active CPAF were dying. Cell 
death induction in cell culture by chlamydial infection has been 
previously documented, and our recent analysis suggests that 
this cell death occurs by a nonapoptotic process (  Ying et al., 
2006  ). When cell death was measured as loss of cellular meta-
bolic activity by MTT assay, it became apparent that most cells 
were dead after 20 h of expression of active CPAF. No decrease 
in viability was measured at 7 h, although very clear morpho-
logical changes were already apparent (  Fig. 6 A  and unpublished 
data). Cell death in this assay was not inhibited by the caspase 
inhibitor zVAD-fmk (  Fig. 6 A  ), consistent with the lack of 
effect of zVAD-fmk in host cell death induced by chlamydial 
infection (  Ojcius et al., 1998  ;   Perfettini et al., 2002  ;   Ying et al., 
2006  ). Because caspase activity is required for apoptotic cell 
death, this is suggestive of a nonapoptotic form of cell death. 
Plasma membrane integrity was relatively well maintained, 
with only     20% of cells taking up the vital dye propidium iodide, 
despite a reduction of metabolic activity of     80% at 20 h of 
treatment with AHT/CM (Fig. S3, available at http://www.jcb
.org/cgi/content/full/jcb.200804023/DC1). 
  During apoptosis, the chromatin condenses and the nuclei 
are fragmented. As these changes in nuclear morphology are a 
good marker of apoptosis, we next analyzed the dying cells for 
changes in nuclear morphology. CPAF activation caused nuclear 
condensation in some cells; however, the morphology was not 
quite typical for apoptosis and distinct from the appearance 
although both proteins were degraded during infection with 
  C. trachomatis   (  Fig. 4 A  ). However, longer periods of CPAF in-
duction in K6 cells did lead to the degradation of Bim and Puma 
(  Fig. 4 A  ). More extensive time-course studies revealed that 
Bim degradation occurred later than cleavage of the other sub-
strates (  Fig. 4 B  ). Although vimentin was already cleaved at 10 h 
after CPAF induction/activation with AHT/CM, the Bim levels 
were unchanged or even increased up to     15 h of CPAF activa-
tion, after which point they began to decrease. At 18 h after acti-
vation, Bim levels were clearly reduced. No smaller fragments 
of Bim were detected (  Fig. 4 B  ; vimentin cleavage starts around 
4 h under this protocol; unpublished data). This suggested that 
the degradation of Bim was not mediated directly by CPAF but 
by subsequent proteolytic events that had been initiated by 
CPAF. This interpretation is supported by another fi  nding: the 
degradation of Bim by prolonged activation of CPAF was 
blocked by lactacystin and MG-132 (  Fig. 4 C  ). The proteolytic 
activity of CPAF, however, is only inhibited by lactacystin but 
not MG-132 (  Zhong et al., 2001  ;   Fig. 2 A  ). It is thus unlikely 
that CPAF directly degrades BH3-only proteins. Nevertheless, 
the CPAF-induced degradation of BH3-only proteins is the 
main reason for apoptosis inhibition in infected cells, and CPAF 
is therefore the main anti-apoptotic factor of   Chlamydia . 
  CPAF expression leads to nonapoptotic 
cell death 
 These results showed that gyrB-CPAF could reproduce the known 
proteolytic events of chlamydial infection. We then turned to the 
  Figure 3.       Infection with   C. trachomatis   or expression of CPAF causes cleav-
age of host cell proteins.   (Left) Infection with   C. trachomatis  . T-REx-293 cells 
were infected with   C. trachomatis   for indicated periods of time. RIPA buffer ex-
tracts of the cells were prepared. (Right) CPAF K6 cells were treated with either 
5 ng/  μ  l AHT, CM, or both for 12  –  14 h as indicated. Triton X-100 cell extracts 
were prepared and all extracts were analyzed by Western blotting using indi-
cated antibodies. The arrowheads indicate speciﬁ  c cleavage products.     JCB • VOLUME 182 • NUMBER 1 • 2008  122
prominent cleavage band was different from the one generated 
during apoptosis; a very light band corresponding to apoptotic 
cleavage appears to be visible on the blot, although the appear-
ance of this band was not sensitive to caspase inhibition (  Fig. 6 E  ). 
Induction of apoptosis by treatment of the cells with TNF/CHX 
yielded the typical caspase-dependent PARP fragment (  Fig. 6 E  ). 
Although PARP cleavage is thus seen upon CPAF activation, it is 
not mediated by caspase-3 but probably by CPAF itself. The rele-
vance of the cleavage of this new CPAF substrate for the infection 
remains to be seen. 
 We  fi nally used electron microscopy for the analysis of 
structural changes in cells containing active CPAF. At earlier 
stages (after 7 h of CPAF expression/activity), although the cells 
had already rounded up and detached from the plate, no ultra-
structural changes were observed (unpublished data). This is 
perhaps somewhat surprising given the strong morphological 
changes, but is in accordance with the unaffected metabolic ac-
tivity at this time. At 20 h, however, only relatively few cells 
were still morphologically intact while the majority were in a 
process of disintegration (  Fig. 7 A, B  ). Only few apoptotic cells 
were detected in this analysis but many necrotic cells, confi  rm-
ing that CPAF induced nonapoptotic (necrotic) cell death in 
CPAF K6 cells. At higher magnifi  cation, dying cells showed 
numerous lamellar structures of unknown composition as well 
as many mitochondria that still seemed only slightly affected 
( Fig. 7 C ). Ectopic expression and activation of CPAF thus causes 
a nonapoptotic form of cell death that appears indistinguishable 
from cell death induced during infection with   C. trachomatis . 
of nuclei in the same cells undergoing apoptosis upon treatment 
with TNF-    /cycloheximide (TNF/CHX) (  Fig. 6 B  ). Higher 
magnifi  cation photographs of the nuclear morphology of cells 
dying due to treatment with TNF/CHX, upon activation of CPAF 
or upon chlamydial infection, are shown in Fig. S4 (available 
at http://www.jcb.org/cgi/content/full/jcb.200804023/DC1). 
Furthermore, unlike the changes induced by the apoptosis-
inducing protocol with TNF/CHX, the CPAF-induced nuclear 
morphological changes were not prevented by the caspase in-
hibitor zVAD-fmk (  Fig. 6 B  ). These results reproduced the fea-
tures of   Chlamydia  -induced cell death and suggested that CPAF 
induced cell death through a nonapoptotic mechanism. 
  Apoptosis is the result of the activation of the apoptotic sig-
nal transduction pathway, and we therefore tested directly whether 
this pathway was activated. Caspase-3 is a central protease in the 
apoptotic pathway, and caspase-3 is regularly activated proteolyt-
ically during apoptosis. An antibody directed against an active 
caspase-3 fragment showed only few positive cells upon activa-
tion of CPAF (treatment with AHT/CM) (  Fig. 6 C  ). Western blot-
ting further failed to detect the cleaved form of caspase-3 seen 
during apoptosis in cells expressing active CPAF (  Fig. 6 D  ), in 
agreement with the absence of caspase-3 activation in cells in-
fected with   C. caviae   or   C. trachomatis   ( Ojcius  et  al.,  1998 ;  Ying 
et al., 2006  ). During apoptosis, caspase-3 cleaves the nuclear en-
zyme poly (ADP-ribose) polymerase (PARP) (  Nicholson et al., 
1995  ), and PARP cleavage can thus be used as a marker of apop-
tosis. Surprisingly, PARP was degraded both during chlamydial 
infection and upon CPAF activation (  Fig. 6 E  ). However, the 
  Figure 4.       BH3-only proteins are degraded by infection with   C. trachomatis   or upon prolonged expression of active CPAF.   (A) (Left) T-REx-293 cells were 
infected with   C. trachomatis   for indicated time points and RIPA buffer extracts were prepared. (Right) CPAF K6 cells were treated with either 5 ng/  μ  l AHT, 
CM, or both as indicated. Cell extracts were analyzed by Western blotting using antibodies speciﬁ  c for Bim, Puma, or actin as loading control. (B) Time 
course of cleavage of CPAF substrates. CPAF K6 cells were treated with 5 ng/  μ  l AHT and CM to induce CPAF expression for the indicated time periods. 
Cell extracts were analyzed by Western blotting. The arrowheads indicate cleavage product of vimentin. (C) Inhibition of Bim degradation by proteasome 
inhibitors. CPAF K6 cells were treated with 5 ng/ml AHT or 5 ng/ml AHT plus CM. 6 h before cell harvesting, either 40   μ  M MG-132 or 5   μ  M clasto-
  lactacystin     -lactone (LC) were added. Cell extracts were analyzed by Western blotting.     123 CYTOPATHICITY OF CPAF   • Paschen et al. 
dying cells, identifying this cell death as nonapoptotic or necrotic. 
All the observed features recapitulated the changes seen in cells 
infected by   C. trachomatis  . Infections with   Chlamydia   com-
monly induce strong infl  ammatory responses. These reactions 
may thus be the result of the CPAF-mediated release of not only 
bacterial but also pro-infl  ammatory cellular molecules. 
  We were prompted to test for the possibility of activation 
by induced proximity by similarities between the known charac-
teristics of CPAF and the well-established process of activation 
  Discussion 
  This study shows that   C. trachomatis   CPAF can be activated 
by oligomerization to induce degradation of host cell proteins. 
On the one hand, CPAF caused the degradation of pro-apoptotic 
BH3-only proteins and is therefore a mediator of chlamydial 
anti-apoptotic activity. On the other hand, CPAF induced cell 
death in the absence of hallmarks of apoptosis. Activation of the 
apoptotic pathway was observed only in a small minority of 
  Figure 5.       CPAF expression leads to changes in cellular morphology.   (A) Changes in cell morphology during CPAF expression. CPAF K6 cells were incu-
bated either with 6 ng/ml AHT, CM, or both for 16 h. Cells were analyzed by light microscopy (left). Arrows indicate smaller vesicular fragments. Black 
bar, 10   μ  m. The right panel shows an enlarged section of either a control sample or a sample treated with AHT and CM. White bar, 3   μ  m. (B) Inhibition of 
CPAF oligomerization by novobiocin. CPAF expression was induced in CPAF K6 cells by adding AHT, or cells were left untreated. 30 min before addition 
of CM, the cells were incubated with indicated amounts of NB. Cells were analyzed by light microscopy. Bar, 10   μ  m.     JCB • VOLUME 182 • NUMBER 1 • 2008  124
or suspected (CPAF) to be autocatalysis, and both form, during 
physiological activation, complexes of the two subunits derived 
from intramolecular cleavage. Our analysis shows that they 
of initiator caspases, especially caspase-9. Both CPAF and cas-
pase-9 are synthesized as zymogens that have low proteolytic 
activity. Both are activated by what has been shown (caspase-9) 
  Figure 6.       CPAF expression causes nonapoptotic cell death.   (A) CPAF reduces cell viability. CPAF K6 or T-REx-293 cells were treated with the indicated 
combinations of TET, CM, and the caspase inhibitor zVAD-fmk (zVAD). As a positive control, cells were treated with TNF-     (TNF) and cycloheximide (CHX). 
After indicated time points, cell viabilities were measured by MTT assay. Relative cell viability was calculated (untreated cells were set to 100%). Data are 
normalized means/SEM of three independent experiments. (B) Analysis of nuclear morphology after CPAF expression by Hoechst staining. CPAF K6 cells 
were treated with 10 ng/ml AHT, CM, or zVAD-fmk as indicated. As a positive control of apoptosis, cells were treated with TNF/CHX (as described in A). 
After 16 h, cells were stained with the Hoechst 33342 dye and analyzed by ﬂ  uorescence microscopy. Bar, 15   μ  m. (C) Caspase-3 activation during CPAF-
expression. CPAF K6 cells were treated as described in B and analyzed by ﬂ  ow cytometry using an antibody speciﬁ  c for active caspase-3. (D) Analysis 
of caspase-3 activation by Western blotting. CPAF K6 cells were treated as described in B, and cell extracts were analyzed by Western blotting using 
an antibody speciﬁ  c for active caspase-3. Arrowheads indicate speciﬁ  c cleavage products of activated caspase-3. Detection of actin served as loading 
control. (E) Cleavage of PARP by infection with   C. trachomatis   or expression of active CPAF. (Left) CPAF K6 cells were infected with   C. trachomatis   for the 
indicated periods of time. (Right) CPAF K6 cells were treated as described in B. Cell extracts were analyzed by Western blotting using a PARP antibody. 
The arrowheads indicate cleavage products resulting from chlamydial infection or CPAF expression. The asterisk indicates a speciﬁ  c PARP cleavage product 
due to caspase activation by TNF/CHX.     125 CYTOPATHICITY OF CPAF   • Paschen et al. 
mammals, and has been worked out in great detail (  Bao and Shi, 
2007  ). Our results suggest that this principle of protease activa-
tion is even much older in evolutionary terms, as it is already 
found in bacteria. CPAF is effi  ciently translocated from the 
  bacteria-harboring vacuole into the cytosol, although the mecha-
nism of this translocation is unclear. Our data indicate that oligo-
merization of CPAF is an essential step in its maturation. This is 
supported by the observation that CPAF secreted from the vacu-
ole into the host cytosol during infection with   C. trachomatis  
was also found in a complex of     200 kD, which probably cor-
responds to 3 – 4 subunits (unpublished data). When and how CPAF 
oligomerizes is unclear. One possibility is that a bacterial chaper-
one binds and translocates CPAF into the host cytosol, during 
which process the spatial requirements for CPAF activation might 
be met. It is also conceivable that CPAF may transiently associate 
with the inclusion membrane at a suffi  ciently high local concen-
tration to cause its own activation. Initiator caspases are activated 
by clustering induced by specifi  c adaptors. In the best character-
ized example, caspase-9 is clustered after heptamerization of its 
adaptor, Apaf-1 (  Bao and Shi, 2007  ). The existence of a specifi  c 
bacterial adaptor for CPAF is therefore also possible. 
  Limited homology between CPAF and Tsp has been ob-
served. Our results show that the Tsp-like active site in   C. tracho-
matis   CPAF is required for its activity.   Chlamydia   has a protein, 
CT441 in   C. trachomatis  , that shows higher similarity to known 
bacterial Tsp and that has recently been characterized (  Lad et al., 
2007  ). The role of Tsp in bacteria is not well understood, but 
these enzymes appear to be involved with proteolytic modifi  ca-
tions and degradation of various bacterial proteins (  Paetzel and 
Dalbey, 1997  ). The conservation of the active site in CPAF might 
be an indication of evolutionary origin, but the low overall ho-
mology suggests that it has assumed other functions. The translo-
cation of CPAF into the host cytosol also indicates that its 
physiological targets may not be bacterial but host cell proteins. 
  It is interesting to note that CPAF both has anti-apoptotic 
activity and induces nonapoptotic cell death, reproducing two 
salient features of chlamydial infection. Although the relevance 
of cell death modulation for chlamydial pathogenesis is not 
known, it is likely that apoptosis inhibition may contribute to 
the ability of chlamydiae to complete their developmental cycle 
and perhaps to maintain persistent human infections. During viral 
infection, the host cell defense often includes the induction of 
apoptosis through the mitochondrial, BH3-only protein controlled 
pathway (  Everett and McFadden, 2002  ). Although   Chlamydia  
differs from viruses in important aspects, it shares their depen-
dency on cellular integrity for its replication. The cell  ’  s response 
to chlamydial infection may include the attempt to undergo apop-
tosis through activation of BH3-only proteins. These proteins are 
general sensors of cell stress and can be activated to induce apop-
tosis in many different situations (  Strasser, 2005  ). It is therefore 
even conceivable that they are activated in response to CPAF 
activity. CPAF might thus induce apoptosis but at the same time 
counter it by causing the degradation of BH3-only proteins. In this 
scenario, as BH3-only proteins are mostly degraded, the net result 
of the activity of CPAF would be the observed nonapoptotic cell 
death. CPAF-induced cell death could therefore be a masked form 
of apoptosis that serves as a cellular defense reaction. 
differ in that a cleavage-defective mutant of CPAF is inactive, 
whereas auto-cleavage defective caspase-9 still can cleave its 
substrates (  Stennicke et al., 1999  ). A mutant carrying a point 
mutation in the CPAF processing site was defective in both pro-
cessing and activity. These results strongly suggest that CPAF is 
activated by an autocatalytic process. Although we cannot ex-
clude the possibility that a cellular protease is involved in gyrB-
CPAF processing, this seems unlikely. 
 The induced proximity model has been initially proposed to 
explain the activation of initiator caspases by adaptor-induced 
clustering during apoptosis. This mode of protease activation is 
conserved between the nematode   Caenorhabditis elegans   and 
  Figure 7.       CPAF expression leads to changes in cellular ultrastructure.   
CPAF K6 cells were treated with 5 ng/ml AHT and CM for 20 h (middle 
and bottom), or left untreated (control; top). Cells were harvested, pelleted, 
and analyzed by electron microscopy. The bottom panel shows a 10-fold 
magniﬁ  cation. Scale bars are indicated. M, mitochondria.     JCB • VOLUME 182 • NUMBER 1 • 2008  126
cells were infected at a MOI = 3. After 2 h, 10% FCS were added. At indi-
cated time points, cells were harvested and lysed by incubation with RIPA 
buffer (1% Triton X-100, 0.5% SDS, 0.5% deoxycholate,1 mM EDTA, 150 mM 
NaCl, and 50 mM Tris, pH 8.0), supplemented with a protease inhibitor 
cocktail (Roche). 
  Transient transfection of T-REx-293 cells and induction of protein expression 
  Transient transfections of T-REx-293 cells were performed using FuGene HD 
(Roche), following the manufacturer  ’  s instructions. CPAF expression was in-
duced by addition of 0.5 ng/  μ  l anhydrotetracycline (AHT; IBA) for 13  –  14 h 
unless otherwise indicated. In some experiments 4   μ  g/ml tetracycline (TET) 
was used. For oligomerization experiments 1   μ  M coumermycin (CM; Sigma-
Aldrich) was added 7 h before harvesting to the cells. When indicated, 
  novobiocin (NB; Sigma-Aldrich) was added 30 min before CM addition. 
  Immunoblotting 
  Cells were harvested and lysed in Triton X-100 buffer (1% Triton X-100, 
1 mM EDTA, 150 mM NaCl, 50 mM Tris, pH 8.0, and protease inhibitor 
cocktail). Cell extracts were separated using SDS-PAGE and proteins 
were transferred onto nitrocellulose membranes. Equivalent amounts of 
protein were loaded and equal loading was conﬁ  rmed by detection of 
    -actin or tubulin using speciﬁ  c antibodies (Sigma-Aldrich). Membranes 
were probed with anti-Bim, anti-cyclin B1, anti-FLAG, anti-myc, anti-PARP, 
anti-Puma (all from Cell Signaling Technology), anti-Bak, anti-Bcl-2 (both 
from BD Biosciences), anti-RFX 5, anti-vimentin, anti-CK8 (all three from 
Acris), or anti-caspase 3 (Abcam) antibodies. Proteins were visualized 
using peroxidase-conjugated secondary antibodies and a chemolumines-
cence detection system (GE Healthcare). 
  Size exclusion chromatography 
  Cells were lysed in 1% Triton X-100 and 1 mM EDTA in PBS, and lysates 
were cleared by centrifugation. NB was used at a concentration of 20   μ  M 
and was added 30 min before chromatography. All extracts were separated 
on a Superose 200 gel ﬁ  ltration column (GE Healthcare). Molecular sizes 
were calculated by plotting the log of the molecular weight of standard 
marker proteins (Sigma-Aldrich) against their elution volume. 
  Cell-free cleavage assay 
  CPAF K6 cells expressing oligomerized CPAF were lysed in NP-40 buffer 
(1% NP-40, 150 mM NaCl, 1 mM EDTA, and 20 mM MOPS, pH 7.4), and 
equivalent amounts of the extract were mixed either with PBS as a control or 
with NP-40 extracts of T-REx-293 cells, transiently transfected with the CK8-
myc construct. Extracts were incubated at 37  °  C for 1 h. CPAF K6 cell ex-
tracts were preincubated with the proteasome inhibitors clasto-lactacystin 
    -lactone (LC; Sigma-Aldrich) or MG-132 (EMD) at 37  °  C for 20 min before 
substrate addition. 
  MTT assay 
  Cell viability was tested by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide; Sigma-Aldrich) assay. MTT was added to cells 
at a concentration of 0.5 mg/  μ  l and incubated at 37  °  C for 1 h. Generated 
formazane crystals were dissolved in DMSO, and the OD at a wavelength 
of 570 nm was measured. As a positive control, cells treated with TNF     
(R  &  D Systems)/cycloheximide (0.5 ng/ml each) for 16 h were used. 
The caspase inhibitor zVAD-fmk was used at a concentration of 25   μ  M. 
  Analysis of cell morphology and detection of apoptosis 
  Cell morphology was analyzed in culture media by light microscopy at RT 
(CKX41 inverted microscope, 40x/0.55 lens, U-CMAD3 video adaptor, 
F-View II Camera, Cell-F Soft Imaging Solution; all from Olympus). 
  For detection of apoptosis, cells were stained with 1   μ  g/  μ  l Hoechst 
33342 dye (Roche) and incubated for 30 min at 37  °  C. Cells were har-
vested, washed with PBS, resuspended in PBS, and embedded in mounting 
ﬂ  uid (Labsystems Oy). Nuclei were examined using an Epiﬂ  uorescence 
  microscope at RT (DMRBE microscope, 40x/0.70 lens, both from Leica; 
AxioCam MRc camera with AxioVision software; Carl Zeiss, Inc.). Adobe 
Photoshop and Microsoft PhotoEditor were used to adjust image size and 
resolution, and to enhance contrast of the whole image for better visibility 
in some pictures. 
  Flow cytometry 
  Caspase-3 activation was detected by ﬂ  ow cytometry analysis. CPAF K6 
cells were harvested, ﬁ  xed in 2% neutral-buffered paraformaldehyde, and 
permeabilized with 0.5% saponin (Sigma-Aldrich). Active caspase-3 was 
detected with an anti-active caspase-3 antibody (Abcam) and FITC-conjugated 
  The molecular mechanism for the cell death  –  inducing 
activity of CPAF is still unknown. The appearance of lamellar 
structures in the cell might suggest changes to organelles and 
  intracellular membranes, such as lysosomes and the ER, and their 
membranes. The ultrastructural changes to these organelles that 
have been described during chlamydial infection ( Todd and Storz, 
1975  ;   Todd et al., 1976  ) are thus likely connected to CPAF activ-
ity, and it could be the release of, for instance, lysosomal pepti-
dases, that causes the damage and eventual death of the cell. 
  All sequenced chlamydial strains have a gene coding for 
CPAF. The genome of an endosymbiont of free-living amoeba, 
  candidatus protochlamydia amoebophila   (UWE25), has recently 
been sequenced, and even this distantly related bacterium carries a 
recognizable CPAF homologue ( Horn et al., 2004 ;  Collingro et al., 
2005 ). This suggests that CPAF serves a function that is similar for 
the different species and perhaps even the very different require-
ments of infection of human cells and amoeba. When fi  rst discov-
ered, CPAF  ’  s activity to degrade transcription factors required for 
MHC-expression was noted. Although such a mechanism might 
contribute to immune evasion by   Chlamydia  , it appears more 
likely that this is not the evolutionarily selected function of CPAF, 
especially not in amoeba lacking MHC. Cytoskeletal structures 
like the intermediate fi  lament components CK8 and vimentin are 
good candidates as essential targets of CPAF activity. The host cell 
cytosol has to accommodate the rapidly growing inclusion, and 
the disruption of intermediate fi  laments might facilitate expansion 
of the inclusion and perhaps eventually the release of the inclusion 
by lysis or extrusion (  Hybiske and Stephens, 2007  ). Whether 
CPAF-induced cell death is benefi  cial for the host or for the 
bacteria is therefore uncertain at this stage. Either way, our results 
strongly suggest that CPAF is an important factor in chlamydial 
pathogenicity, and cellular alterations and responses induced by 
CPAF might be involved in causing protracted infections. 
  Materials and methods 
  Cloning of expression vectors 
  A fragment encoding for amino acid residues 2  –  221 of gyrB of   E. coli   was 
ampliﬁ  ed by PCR and cloned into a pcDNA4/TO/  myc  -His vector (Invitro-
gen). Consecutively, two additional gyrB fragments, separated by linker se-
quences of 16 amino acid residues, were inserted 5     of the ﬁ  rst copy. 
A sequence coding for a FLAG tag was added 3     of the gyrB fragments (gyrB 
construct). The coding sequence of CPAF of   C. trachomatis   (amino acid resi-
dues 18  –  601) was inserted behind the FLAG-gyrB construct (gyrB-CPAF). 
CPAF mutants were generated by point mutations using a Stratagene XL 
Mutagenesis kit. The open reading frame of human cytokeratin 8 (CK8; ATCC 
#61515) was ampliﬁ  ed by PCR, thereby adding a myc-tag coding sequence 
to the 3     end and cloned into a pENTR/SD/D-TOPO vector (Invitrogen). 
Subsequently, the CK8-myc fragment was shufﬂ  ed into a pcDNA6.2/
V5-DEST (CK8-myc construct) by Gateway LR reaction, according to the 
manufacturer  ’  s instructions (Invitrogen). 
  Cell lines and cell culture 
  The human embryonic kidney cell line, T-REx-293, and T-REx-HeLa cells, 
which stably express the tetracycline repressor (Invitrogen), were grown and 
maintained in humidiﬁ  ed air containing 5% CO  2   at 37  °  C in DMEM supple-
mented with 10% fetal calf serum (tetracycline negative; PAA Laboratories), 
50   μ  g/  μ  l penicillin/streptomycin, and 5   μ  g/  μ  l blasticidin. T-REx-293 clones 
stably expressing gyrB-CPAF were generated by electroporation with the 
construct and antibiotic selection. 
  Chlamydial infections of T-REx-293 cells 
  The   C. trachomatis   strain L2 was obtained from ATCC. Before infection, the 
culture medium was replaced with DMEM without FCS and antibiotics, and 127 CYTOPATHICITY OF CPAF   • Paschen et al. 
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goat anti  –  rabbit secondary antibody (Dianova). Flow cytometric analysis 
was performed with a FACSCalibur (Becton Dickinson). 
  Electron microscopy 
  Cells were harvested and ﬁ  xed in 2.5% glutaraldehyde in 0.1 M sodium 
cacodylate buffer (pH 7.4; Electron Microscopy Sciences) and embedded 
in epoxy resin (epon 812; Electron Microscopy Sciences). Ultrathin sec-
tions were examined with an EM 10 CR transmission electron microscope 
(Carl Zeiss, Inc.). For image acquisition, a MegaView III camera system 
(Olympus) was used. 
  Online supplemental material 
  Fig. S1 shows the morphological changes in T-REx-293 and T-REx-HeLa 
cells, respectively, due to transient transfection of CPAF. Fig. S2 compares the 
changes in cellular morphology between infection with   C. trachomatis   and 
the expression of CPAF in CPAF K6 cells. Fig. S3 describes the cell viability of 
CPAF K6 cells after CPAF induction measured by propidium iodide uptake. 
Fig. S4 shows nuclear morphology after CPAF expression or infection with 
  C. trachomatis   at higher magniﬁ  cation. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200804023/DC1. 
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